首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Myeloablative Timed Sequential Busulfan is Safe and Appears Promising in Older Patients with AML/MDS

【24h】

Myeloablative Timed Sequential Busulfan is Safe and Appears Promising in Older Patients with AML/MDS

机译：清髓性定时序贯白消安是安全的，在AML / MDS的老年患者中似乎很有希望

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation》 |2016年第1期|共2页
作者
Popat Uday R.; Lyons Genevieve; Bassett Roland; Chen Julianne; Valdez Ben C.; Kawedia Jitesh D.; Ahmed Sairah; Alousi Amin M.; Anderlini Paolo; Bashier Qaiser; Ciurea Stefan O.; Hosing Chitra; Jones Roy B.; Kebriaei Partow; Khouri Issa F.; Marin David; Nieto Yago; Olson Amanda; Oran Betul; Parmar Simrit; Patel Krina; Qazilbash Muzaffar H.; Rezvani Katy; Shah Nina; Shpall Elizabeth J.; Andersson Borje S.; Champlin Richard E.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词
入库时间 2022-08-18 09:02:18

相似文献

外文文献
中文文献
专利

1. Myeloablative Timed Sequential Busulfan is Safe and Appears Promising in Older Patients with AML/MDS [J] . Popat Uday R., Lyons Genevieve, Bassett Roland, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第3Suppla1期

机译：清髓性定时序贯白消安是安全的，在AML / MDS的老年患者中似乎很有希望
2. Reduced intensity vs. myeloablative conditioning with fludarabine and PK-guided busulfan in allogeneic stem cell transplantation for patients with AML/MDS [J] . Alatrash Gheath, Kidwell Kelly M., Thall Peter F., Bone marrow transplantation . 2019,第8期

机译：用氟拉马岛和PK-引导的Busulfan在异种干细胞移植中的氟胂和PK引导的血管突变，对AML / MDS的患者进行降低的强度与霉菌调节
3. Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia: long-term results of a prospective phase II clinical trial [J] . Rohtesh S. Mehta, Roland Bassett, Amanda Olson, Haematologica . 2019,第12期

机译：定时序贯白消安加氟达拉滨对老年急性髓性白血病患者的清髓性调理：前瞻性II期临床试验的长期结果
4. Intravenous Busulfan Reduces Toxicity Associated with Myeloablative Allogeneic Hematopoietic Transplantation in Patients with Myeloid Malignancies [C] . A. Shimoni, B. Bxelorai, I. Hardan, European Haematology Association . 2002

机译：静脉内的伯鲁兰减少骨髓恶性肿瘤患者患有髓鞘异产造血移植的毒性
5. Time spent in complete remission (CR) and overall survival (OS) in AML patients. [D] . Sandhu, Vicky. 2014

机译：AML患者花费在完全缓解（CR）和总体生存（OS）上的时间。
6. Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia: long-term results of a prospective phase II clinical trial [O] . Rohtesh S. Mehta, Roland Bassett, Amanda Olson, 2019

机译：定时序贯白消安加氟达拉滨对老年急性髓性白血病患者的清髓性调理：前瞻性II期临床试验的长期结果
7. Pretransplant conditioning with IV busulfan (Bu) and fludarabine (Flu) as alternative to Bu and cyclophosphamide (Cy)—a safe, myeloablative regimen with high antileukemic efficacy in AML/MDS [O] . de Lima M., Couriel D., Shahjahan M., 2005

机译：移植前用IV丁硫磺（Bu）和氟达拉滨（Flu）代替Bu和环磷酰胺（Cy）进行预处理-一种安全，清髓的方案，在AML / MDS中具有高抗白血病功效

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号